A detailed history of New York State Common Retirement Fund transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 179,774 shares of NBIX stock, worth $24.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
179,774
Previous 208,407 13.74%
Holding current value
$24.5 Million
Previous $28.7 Million 27.8%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$114.58 - $153.15 $3.28 Million - $4.39 Million
-28,633 Reduced 13.74%
179,774 $20.7 Million
Q2 2024

Jul 31, 2024

BUY
$130.86 - $143.19 $266,823 - $291,964
2,039 Added 0.99%
208,407 $28.7 Million
Q1 2024

May 07, 2024

SELL
$130.4 - $143.74 $1.05 Million - $1.15 Million
-8,028 Reduced 3.74%
206,368 $28.5 Million
Q4 2023

Feb 01, 2024

SELL
$106.07 - $132.76 $3.12 Million - $3.91 Million
-29,456 Reduced 12.08%
214,396 $28.2 Million
Q3 2023

Nov 07, 2023

BUY
$94.02 - $117.1 $2.87 Million - $3.58 Million
30,539 Added 14.32%
243,852 $27.4 Million
Q2 2023

Aug 07, 2023

BUY
$89.53 - $104.87 $791,803 - $927,470
8,844 Added 4.33%
213,313 $20.1 Million
Q1 2023

May 02, 2023

SELL
$94.11 - $123.02 $2.43 Million - $3.17 Million
-25,770 Reduced 11.19%
204,469 $20.7 Million
Q4 2022

Jan 30, 2023

SELL
$106.72 - $127.06 $4.67 Million - $5.56 Million
-43,761 Reduced 15.97%
230,239 $27.5 Million
Q3 2022

Nov 08, 2022

BUY
$92.03 - $107.81 $2.14 Million - $2.5 Million
23,213 Added 9.26%
274,000 $29.1 Million
Q2 2022

Aug 04, 2022

BUY
$75.79 - $100.07 $473,763 - $625,537
6,251 Added 2.56%
250,787 $24.4 Million
Q1 2022

May 05, 2022

BUY
$72.45 - $94.81 $2.28 Million - $2.98 Million
31,479 Added 14.77%
244,536 $22.9 Million
Q4 2021

Feb 02, 2022

BUY
$79.65 - $106.22 $157,468 - $209,996
1,977 Added 0.94%
213,057 $18.1 Million
Q3 2021

Nov 02, 2021

SELL
$86.18 - $99.03 $3.4 Million - $3.91 Million
-39,506 Reduced 15.77%
211,080 $20.2 Million
Q2 2021

Aug 02, 2021

SELL
$89.43 - $102.27 $215,615 - $246,572
-2,411 Reduced 0.95%
250,586 $24.4 Million
Q1 2021

May 11, 2021

SELL
$87.57 - $119.4 $902,759 - $1.23 Million
-10,309 Reduced 3.92%
252,997 $24.6 Million
Q4 2020

Feb 08, 2021

BUY
$86.91 - $108.33 $3.31 Million - $4.12 Million
38,035 Added 16.88%
263,306 $25.2 Million
Q3 2020

Nov 05, 2020

BUY
$96.16 - $135.15 $4.19 Million - $5.89 Million
43,563 Added 23.97%
225,271 $21.7 Million
Q2 2020

Aug 07, 2020

SELL
$85.09 - $130.36 $815,757 - $1.25 Million
-9,587 Reduced 5.01%
181,708 $22.2 Million
Q1 2020

May 06, 2020

SELL
$75.11 - $113.76 $56,708 - $85,888
-755 Reduced 0.39%
191,295 $16.6 Million
Q4 2019

Feb 05, 2020

SELL
$86.8 - $118.57 $5.33 Million - $7.29 Million
-61,447 Reduced 24.24%
192,050 $20.6 Million
Q3 2019

Nov 07, 2019

BUY
$83.82 - $101.5 $108,127 - $130,935
1,290 Added 0.51%
253,497 $22.8 Million
Q2 2019

Aug 09, 2019

BUY
$72.24 - $91.27 $593,957 - $750,421
8,222 Added 3.37%
252,207 $21.3 Million
Q1 2019

May 08, 2019

SELL
$69.31 - $91.53 $1.24 Million - $1.64 Million
-17,929 Reduced 6.85%
243,985 $21.5 Million
Q4 2018

Feb 08, 2019

SELL
$68.32 - $124.36 $876,545 - $1.6 Million
-12,830 Reduced 4.67%
261,914 $18.7 Million
Q3 2018

Nov 07, 2018

SELL
$98.88 - $125.85 $5,438 - $6,921
-55 Reduced 0.02%
274,744 $33.8 Million
Q2 2018

Aug 10, 2018

SELL
$75.3 - $105.99 $1.37 Million - $1.93 Million
-18,175 Reduced 6.2%
274,799 $27 Million
Q1 2018

May 10, 2018

SELL
$75.88 - $92.43 $76,638 - $93,354
-1,010 Reduced 0.34%
292,974 $24.3 Million
Q4 2017

Feb 13, 2018

BUY
$58.53 - $77.59 $1.97 Million - $2.61 Million
33,688 Added 12.94%
293,984 $22.8 Million
Q3 2017

Nov 06, 2017

BUY
$47.97 - $61.28 $234,813 - $299,965
4,895 Added 1.92%
260,296 $16 Million
Q2 2017

Aug 11, 2017

BUY
N/A
255,401
255,401 $11.7 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.